ABSI News and Press, Absci Corporation From 11/09/21

Absci (NASDAQ:ABSI): Q3 GAAP EPS of -$0.33 misses by $0.14. Revenue of $1.53M (+68.1% Y/Y) misses by $0.48M. Press Release For further details see: Absci EPS misses by $0.14, misses on revenue

VANCOUVER, Wash., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today reported financial and operating results for the quarter ended...

VANCOUVER, Wash., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced it will be participating virtually in the following ...

VANCOUVER, Wash., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced the opening of its new campus located in Vancouver, ...

VANCOUVER, Wash., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins, today announced it will report financial results for the third quart...

Absci’s AI-powered discovery and development platform to further expand EQRx’s portfolio of innovative, affordable medicines EQRx, a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower...

VANCOUVER, Wash., Sept. 13, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins, today announced the company will be participating virtually in the upc...

Coinbase (NASDAQ:COIN) represented one of the biggest topics of conversation on Wall Street during midday action on Wednesday. Shares dipped following a dispute with regulators over its Lend product. PayPal (NASDAQ:PYPL) also took its share of the spotlight. A multi-billion purchase weighed o...

Gainers: Kadmon (NASDAQ:KDMN) +73%. ICU Medical (NASDAQ:ICUI) +32%. Candel Therapeutics (NASDAQ:CADL) +23%. Globalstar (NYSE:GSAT) +22%. Spectrum Brands (NYSE:SPB) +20%. Vinco Ventures (NASDAQ:BBIG) +19%. WISeKey (NASDAQ:WKEY) +14%. SilverBow (NYSE:SBOW) +16%. Aterian (NASDAQ:ATER) +16%. Gain...

VANCOUVER, Wash., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), the drug and target discovery company harnessing deep learning and synthetic biology to expand the therapeutic potential of proteins, today reported financial and operating results for the quarter ended J...